Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
31 /100
MEDIUM RISK
Score updated Aug 28, 2026

ANRO — Alto Neuroscience, Inc. Dilution Risk Tracker

Track ANRO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ANRO — Get alerts when the score changes →

As of August 28, 2026, Alto Neuroscience, Inc. (ANRO) has a DilutionWatch DilutionScore of 31/100, rated MEDIUM dilution risk. Alto Neuroscience, Inc. has a market capitalization of $704.34M, 39.24M shares outstanding, 112 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $120.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

Watch
Minor dilution signals detected
model est. 10%
💰 Capital Raise model 20%
• Active shelf registration ($120M, 17% of market cap)
🔔 Track ANRO — Get forecast alerts →

Market Data

Market Cap$704.34M
Shares Outstanding39.24M
Float23.95M
Cash$243.73M
Debt$16.19M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 27.2% shares (2026Q1 vs prior)
112 institutional holders · 31.97M shares
#1 PERCEPTIVE ADVISORS LLC 4.02M shares
#2 Alpha Wave Global, LP 3.71M shares
#3 Commodore Capital LP 2.72M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.24M
Days to Cover7.5
% of Float13.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31
xbrl XBRL WARRANT 2025-12-31
EFFECT EFFECT 2026-04-20
S-3 SHELF 2026-04-10
8-K 8K EVENT 2026-03-16
Full SEC filing analysis available with free account

Recent News

No recent news

Factual ANRO Dilution Snapshot

Alto Neuroscience, Inc. (ANRO) has a DilutionScore of 31/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ANRO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ANRO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ANRO
ANRO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.